Skip to content

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04343898
Acronym
STOP-COVID
Enrollment
5154
Registered
2020-04-13
Start date
2020-04-01
Completion date
2023-07-01
Last updated
2023-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infection

Brief summary

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Detailed description

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Interventions

OTHERNo intervention

Observational

Sponsors

Icahn School of Medicine at Mount Sinai
CollaboratorOTHER
Montefiore Medical Center
CollaboratorOTHER
Baylor College of Medicine
CollaboratorOTHER
Baylor Health Care System
CollaboratorOTHER
Beth Israel Deaconess Medical Center
CollaboratorOTHER
University of Colorado, Denver
CollaboratorOTHER
Cook County Hospital
CollaboratorOTHER
The Cooper Health System
CollaboratorOTHER
Duke University
CollaboratorOTHER
Georgetown University
CollaboratorOTHER
Hackensack mountainside hospital
CollaboratorUNKNOWN
Hackensack Meridian Health
CollaboratorOTHER
Indiana University Health Methodist Hospital
CollaboratorOTHER
Johns Hopkins University
CollaboratorOTHER
Loma Linda University
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Medical College of Wisconsin
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
Weill Medical College of Cornell University
CollaboratorOTHER
NYU Langone Health
CollaboratorOTHER
Ochsner Health System
CollaboratorOTHER
Oregon Health and Science University
CollaboratorOTHER
Renown Health
CollaboratorOTHER
Rush University Medical Center
CollaboratorOTHER
New Jersey Medical School
CollaboratorOTHER
Rutgers Robert Wood Johnson Medical School
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Temple University
CollaboratorOTHER
Tufts Medical Center
CollaboratorOTHER
Tulane University
CollaboratorOTHER
University of California, Davis
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER
University Hospitals Cleveland Medical Center
CollaboratorOTHER
University Medical Center of Southern Nevada
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
University of Chicago
CollaboratorOTHER
University of Florida
CollaboratorOTHER
University of Illinois at Chicago
CollaboratorOTHER
University of Kentucky
CollaboratorOTHER
University of Miami
CollaboratorOTHER
University of Michigan
CollaboratorOTHER
University of Oklahoma
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
University of Pittsburgh Medical Center
CollaboratorOTHER
University of Tennessee
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of Texas, Southwestern Medical Center at Dallas
CollaboratorOTHER
Yale University
CollaboratorOTHER
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(each of the following): 1. Adults (aged ≥18 years) 2. Laboratory-confirmed diagnosis of COVID-19 3. Hospitalized in the ICU for illness related to COVID-19

Exclusion criteria

-None

Design outcomes

Primary

MeasureTime frame
28-Day Mortality28-days from the day of ICU admission

Secondary

MeasureTime frame
60-Day Mortality60-days from the day of ICU admission
90-Day Mortality90-days from the day of ICU admission

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026